Effects of Blockade of the Renin-Angiotensin and Endothelin Systems on Experimental Bronchiolitis Obliterans

Journal of Heart and Lung Transplantation

Volumn 25, Issue 11, 2006, Pages 1324-1329

  Antus, Balazs ^a   Sebe, Attila ^b   Fillinger, Janos ^a   Jeney, Csaba ^b   Horvath, Ildiko ^a  

^a NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^b Genoid Ltd   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; PLATELET DERIVED GROWTH FACTOR; RAMIPRIL; RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DRUG EFFECT; MALE; MONOTHERAPY; MORPHOMETRICS; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRACHEA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRONCHIOLITIS OBLITERANS; DRUG THERAPY, COMBINATION; ENDOTHELINS; GENE EXPRESSION REGULATION; MALE; NECROSIS; PLATELET-DERIVED GROWTH FACTOR; RAMIPRIL; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECEPTORS, ENDOTHELIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SULFONAMIDES; TRACHEA; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750689588     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.08.007     Document Type: Article

References (30)

1. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
2. Hele D.J., Yacoub M.H., and Belvisi M.G. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res 2 (2001) 169-183
3. Maclean A.A., Liu M., Fischer S., Suga M., and Keshavjee S. Targeting the angiotensin system in posttransplant airway obliteration: the antifibrotic effect of angiotensin converting enzyme inhibition. Am J Respir Crit Care Med 162 (2000) 310-315
4. Tikkanen J.M., Koskinene P.K., and Lemstrom K.B. Role of endogenous endothelin-1 in transplant obliterative airway disease in the rat. Am J Transplant 4 (2004) 713-720
5. Benigni A., Corna D., Maffi R., Benedetti G., Zoja C., and Remuzzi G. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int 54 (1998) 353-359
6. Amann K., Simonaviciene A., Medwedewa T., et al. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. J Am Soc Nephrol 12 (2001) 2572-2584
7. Adams J., Odoni G., Ogata H., et al. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model. Nephrol Dial Transplant 17 (2002) 780-787
8. Boehler A., Bai X.H., Liu M., et al. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med 159 (1999) 1910-1917
9. Aris R.M., Walsh S., Chalermskulrat W., Hathwar V., and Neuringer I.P. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 166 (2002) 417-422
10. Farhy R.D., Peterson E., and Scicli A.G. Kinins and the events influenced by an angiotensin-converting enzyme inhibitor during neointima formation in the rat carotid artery. J Hypertens 15 (1997) 421-429
11. Reichenspurner H., Soni V., Nitschke M., et al. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents. Transplantation 64 (1997) 373-383
12. Antus B., Hamar P., Kokeny G., et al. Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant 18 (2003) 54-61
13. Ruggenenti P. Chronic allograft nephropathy. A multiple approach to target nonimmunological factors. Contrib Nephrol 146 (2005) 87-94
14. Orbaek A.H. Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts. Atherosclerosis 142 (1999) 243-263
15. Kobayashi J., Crawford S.E., Backer C.L., et al. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. Circulation 88 suppl (1993) II-286-II-290
16. Schersten H., Hedner T., McGregor C.G., et al. Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts. J Thorac Cardiovasc Surg 111 (1996) 253-258
17. Aarnio P., Tukiainen P., Taskinen E., Harjula A., and Fyhrquist F. Endothelin in bronchoalveolar lavage fluid is increased in lung-transplanted patients. Scand J Thorac Cardiovasc Surg 30 (1996) 113-116
18. Shennib H., Serrick C., Saleh D., Adoumie R., Stewart D.J., and Giaid A. Alterations in bronchoalveolar lavage and plasma endothelin-1 levels early after lung transplantation. Transplantation 59 (1995) 994-998
19. Takeda S., Sawa Y., Minami M., et al. Experimental bronchiolitis obliterans induced by in vivo HVJ-liposome-mediated endothelin-1 gene transfer. Ann Thorac Surg 63 (1997) 1562-1567
20. Glassberg M.K., Ergul A., Wanner A., and Puett D. Endothelin-1 promotes mitogenesis in airway smooth muscle cells. Am J Respir Cell Mol Biol 10 (1994) 316-321
21. Marini M., Carpi S., Bellini A., Patalano F., and Mattoli S. Endothelin-1 induces increased fibronectin expression in human bronchial epithelial cells. Biochem Biophys Res Commun 220 (1996) 896-899
22. Sun G., Stacey M.A., Bellini A., Marini M., and Mattoli S. Endothelin-1 induces bronchial myofibroblast differentiation. Peptides 18 (1997) 1449-1451
23. El-Gamel A., Sim E., Hasleton P., et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 18 (1999) 828-837
24. Alpers C.E., Davis C.L., Barr D., Marsh C.L., and Hudkins K.L. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 148 (1996) 439-451
25. Yoshida M., Sakuma J., Hayashi S., et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc Natl Acad Sci USA 92 (1995) 9570-9574
26. Hertz M.I., Henke C.A., Nakhleh R.E., et al. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci USA 89 (1992) 10385-10389
27. Sihvola R.K., Pulkkinen V.P., Koskinen P.K., and Lemstrom K.B. Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis. JAMA 39 (2002) 710-717
28. McKay S., de Jongste J.C., Saxena P.R., and Sharma H.S. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol 18 (1998) 823-833
29. Marshall R.P., McAnulty R.J., and Laurent G.J. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161 (2000) 1999-2004
30. Silverborn M., Ambring A., Nilsson F., Friberg P., and Jeppsson A. Blunted vascular response to endothelin-A receptor blockade in cyclosporine-treated lung transplant recipients. J Heart Lung Transplant 24 (2005) 665-670